Published Online
on February 1, 2007

A more recent version of this article appeared on March 1, 2007

This Article Full Text (PDF) All Versions of this Article: 38/3/1110    most recent 01.STR.0000258216.83927.6av1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ovbiagele, B. Articles by Saver, J. L. Search for Related Content PubMed PubMed Citation Articles by Ovbiagele, B. Articles by Saver, J. L. Pubmed/NCBI databases Medline Plus Health Information Statins Stroke Transient Ischemic Attack Related Collections Secondary prevention Cerebrovascular disease/stroke Risk Factors Other Stroke Treatment - Medical Transient Ischemic Attacks Lipid and lipoprotein metabolism

Submitted on October 9, 2006
Accepted on October 11, 2006

Intensive Statin Therapy After Stroke or Transient Ischemic Attack. A Sparcling Success?

Bruce Ovbiagele MD^* and Jeffrey L. Saver MD

From the Stroke Center and Department of Neurology, University of California Los Angeles (UCLA) School of Medicine, Calif.

^* To whom correspondence should be addressed. E-mail: Ovibes{at}mednet.ucla.edu.

Key words: prevention • statins • stroke • TIA

This article has been cited by other articles:

				A. Arboix Potential Impact of Sulfonylureas in the Outcome of Type 2 Diabetic Patients With Ischemic Stroke Stroke, September 1, 2007; 38(9): 2413 - 2414. [Full Text] [PDF]